On March 4th, an agreement was signed with the “Dale que valen” Foundation, dedicated to comprehensively improving the quality of life of people with cerebral palsy and their families.
The purpose of the agreement is to establish a framework for collaboration between DQV and Gistem Research to promote the development of the research project “Exploration of the therapeutic effect of intrasanal application of secretome derived from mesenchymal stem cells of the human uterine cervix in cerebral palsy.”
This project encompasses the entire cycle up to obtaining therapeutic solutions, medications, or treatment protocols that can be effectively applied to patients with cerebral palsy.
